Annual report pursuant to Section 13 and 15(d)

Non-Controlling Interests (Tables)

v3.20.1
Non-Controlling Interests (Tables)
12 Months Ended
Dec. 31, 2019
Non-Controlling Interests  
Schedule of non-controlling interests in consolidated entities

Non-controlling interests in consolidated entities are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

    

For the twelve months ended

    

 

    

    

    

 

 

 

 

As of December 31, 2019

 

December 31, 2019

 

As of December 31, 2019

 

 

 

 

 

 

 

 

Net loss attributable to non-

 

Non-controlling interests 

 

Non-controlling 

 

($ in thousands)

 

NCI equity share

 

controlling interests

 

in consolidated entities

 

ownership

 

Aevitas

 

$

(1,249)

 

$

(694)

 

$

(1,943)

 

35.8

%

Avenue 2

 

 

24,269

 

 

(19,011)

 

 

5,258

 

77.3

%

Baergic

 

 

23

 

 

(1,162)

 

 

(1,139)

 

33.0

%

Cellvation

 

 

(732)

 

 

(158)

 

 

(890)

 

20.6

%

Checkpoint 1

 

 

29,389

 

 

(14,687)

 

 

14,702

 

78.0

%

Coronado SO

 

 

(290)

 

 

 —

 

 

(290)

 

13.0

%

Cyprium

 

 

(320)

 

 

(99)

 

 

(419)

 

10.6

%

Helocyte

 

 

(4,322)

 

 

(402)

 

 

(4,724)

 

19.3

%

JMC

 

 

(211)

 

 

325

 

 

114

 

6.9

%

Mustang 2

 

 

62,025

 

 

(25,727)

 

 

36,298

 

70.3

%

Tamid

 

 

(565)

 

 

(85)

 

 

(650)

 

22.8

%

Total

 

$

108,017

 

$

(61,700)

 

$

46,317

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

For the twelve months ended

    

 

    

    

 

 

 

As of December 31, 2018

 

December 31, 2018

 

As of December 31, 2018

 

 

 

 

 

 

 

 

 

Net loss attributable to

 

Non-controlling interests in

 

Non-controlling

 

($ in thousands)

 

NCI equity share

 

non-controlling interests

 

consolidated entities

 

ownership

 

Aevitas

 

$

(474)

 

$

(606)

 

$

(1,080)

 

36.1

%

Avenue 2

 

 

13,326

 

 

(13,735)

 

 

(409)

 

64.81

%

Caelum3

 

 

(2,436)

 

 

(2,413)

 

 

(4,849)

 

36.8

%

Cellvation

 

 

(457)

 

 

(185)

 

 

(642)

 

21.1

%

Checkpoint 1

 

 

31,648

 

 

(23,470)

 

 

8,178

 

69.3

%

Coronado SO

 

 

(290)

 

 

 —

 

 

(290)

 

13.0

%

Cyprium

 

 

(210)

 

 

(62)

 

 

(272)

 

10.8

%

Helocyte

 

 

(3,372)

 

 

(684)

 

 

(4,056)

 

19.8

%

JMC

 

 

(475)

 

 

245

 

 

(230)

 

6.9

%

Mustang 2

 

 

38,631

 

 

(16,628)

 

 

22,003

 

60.5

%

Tamid

 

 

(211)

 

 

(251)

 

 

(462)

 

23.4

%

Total

 

$

75,680

 

$

(57,789)

 

$

17,891

 

 

 


Note 1:   Checkpoint is consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Checkpoint’s Class A Common Shares which provide super-majority voting rights.

Note 2:  Avenue and Mustang are consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Preferred Class A Shares which provide super-majority voting rights.

Note  3:  Effective January 30, 2019, Caelum ceased to be a controlled Fortress entity and as such is no longer consolidated.